| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 65.00K | 135.00K | 550.00K | 382.00K | 400.00K |
| Gross Profit | -304.00K | 12.00K | 522.00K | 301.00K | 400.00K |
| EBITDA | -20.07M | -16.94M | -18.16M | -15.68M | -14.73M |
| Net Income | -20.17M | -18.43M | -19.79M | -17.36M | -15.71M |
Balance Sheet | |||||
| Total Assets | 21.09M | 29.12M | 24.03M | 26.73M | 36.06M |
| Cash, Cash Equivalents and Short-Term Investments | 19.21M | 26.77M | 19.53M | 21.18M | 28.70M |
| Total Debt | 1.99M | 1.98M | 3.64M | 4.88M | 6.54M |
| Total Liabilities | 2.71M | 4.05M | 5.86M | 6.42M | 7.68M |
| Stockholders Equity | 18.38M | 25.08M | 18.17M | 20.31M | 28.38M |
Cash Flow | |||||
| Free Cash Flow | -14.87M | -13.25M | -14.59M | -12.54M | -12.55M |
| Operating Cash Flow | -14.87M | -13.24M | -14.56M | -12.50M | -12.44M |
| Investing Cash Flow | 951.00K | 6.08M | -6.75M | -39.00K | -109.00K |
| Financing Cash Flow | 7.35M | 20.34M | 12.71M | 5.02M | 3.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | $260.34M | -455.60 | -0.91% | ― | -0.41% | -134.49% | |
56 Neutral | $202.27M | -6.57 | -44.72% | ― | -21.59% | -254.69% | |
55 Neutral | $202.77M | -8.00 | -116.86% | ― | -94.26% | 3.20% | |
52 Neutral | $2.56B | -94.88 | -9.12% | ― | -4.54% | -119.39% | |
46 Neutral | $50.55M | ― | -120.36% | ― | 2.80% | ― | |
42 Neutral | $78.63M | -8.72 | -24.81% | ― | -42.77% | 83.21% |
On February 23, 2026, Atomera Incorporated entered into a securities purchase agreement with institutional investors for a registered direct offering of 5,000,000 common shares at $5.00 each, for expected gross proceeds of $25 million. The deal, conducted under an effective shelf registration, was scheduled to close on or about February 24, 2026, with Craig-Hallum Capital Group acting as sole placement agent.
Atomera plans to use the net proceeds for working capital and general corporate purposes, strengthening its financial flexibility as it advances its semiconductor materials licensing business. The company, its executives and directors agreed to 90-day restrictions on additional stock issuances and insider share disposals, aligning stakeholders during the immediate post-offering period.
The most recent analyst rating on (ATOM) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Atomera stock, see the ATOM Stock Forecast page.